BIOENGINEER.ORG

AURORA, Colo. (Dec. 20, 2017) - Researchers from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, selected to estimate the cost-effectiveness of...

Many brain tumor patients do not receive adequate end-of-life care

While more than 60 percent of patients with the brain tumors called malignant gliomas enroll in hospice services, almost a quarter of them do so...

Harnessing sperm to treat gynecological diseases

Credit: American Chemical Society Delivering drugs specifically to cancer cells is one approach researchers are taking to minimize treatment side effects. Stem cells, bacteria and...

Results from Alliance CABOSUN trial lead to US FDA approval of extended indication

The Alliance for Clinical Trials in Oncology (the Alliance), in conjunction with industry partner Exelixis, today announced that the U.S. Food and Drug Administration (FDA)...

Overlooked immune cells hold breakthrough for treating aggressive cancers

Credit: Medical University of South Carolina The latest generation of cancer treatments spring from the discovery that the human immune system is able to beat...

NIH study uncovers clues about why common cancer drug causes hearing loss

Scientists have found a new way to explain the hearing loss caused by cisplatin, a powerful drug used to treat many forms of cancer. Using...

Ludwig researchers uncover mechanism behind metabolic vulnerability of some breast cancers

Credit: Ludwig Cancer Research DECEMBER 19, 2017, New York -- Scientists have known since the 1980s that many cancer cells are relatively sensitive to the...

DNA annotations predict patient outcomes in childhood leukemia

UC San Francisco physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia (JMML) will respond to treatment, and may also...

Novel combination therapy shown to be effective in ovarian cancer

PHILADELPHIA -- (Dec. 19, 2017) -- Researchers at The Wistar Institute have found that combining PARP inhibitors, recently approved for the treatment of BRCA-mutant ovarian...

Monocytes have many faces

Credit: © Foto: Barbara Frommann/Uni Bonn When the immune system mobilizes its troops, antigen-presenting cells play an important role. They can emerge from white blood...

Discovery of unsuspected flexibility offers new pathway to cancer drug development

Credit: Kathryn Faith Blood vessels are the supply lines of the human body, bringing nutrients and oxygen to cells and carrying away waste. Controlling the...

Researchers find possible markers for earlier diagnosis of aggressive tongue cancer

Squamous cell carcinoma of the tongue, also known as oral tongue cancer, is an aggressive form of cancer that generally affects older people. Patients with...

New measurements to guide radiation therapy

Credit: Vincent Lemelin, Université de Sherbrooke, Québec, Canada WASHINGTON, D.C., December 19, 2017 -- When ionizing radiation passes through living tissue, it interacts with molecules...

New $10.8 NIH grant supports KU research into cancer, neurological disorders, lung and heart disease

Credit: KU News Service LAWRENCE -- The University of Kansas' Center for Molecular Analysis of Disease Pathways, a National Institutes of Health Center of Biomedical...

The not so sweet side of Christmas